Zyvox(R) Annual Appraisal of Potency and Spectrum (ZAAPS) Program: report of linezolid activity over 9 years (2004-12) | Zendy

Rodrigo E. Mendes | Zendy; Patricia A. Hogan | Zendy; Jennifer M Streit | Zendy; Ronald N. Jones | Zendy; Robert K. Flamm | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Zyvox(R) Annual Appraisal of Potency and Spectrum (ZAAPS) Program: report of linezolid activity over 9 years (2004-12)

Author(s) -

Rodrigo E. Mendes,

Patricia A. Hogan,

Jennifer M Streit,

Ronald N. Jones,

Robert K. Flamm

Publication year - 2014

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkt541

Subject(s) - linezolid , broth microdilution , microbiology and biotechnology , 23s ribosomal rna , staphylococcus aureus , potency , cons , multilocus sequence typing , minimum inhibitory concentration , vancomycin , biology , medicine , antibiotics , bacteria , in vitro , genetics , genotype , ribosome , rna , gene , computer science , programming language

To summarize the activity and spectrum of linezolid and comparators tested against 7972 Gram-positive clinical isolates as part of the Zyvox(®) Annual Appraisal of Potency and Spectrum (ZAAPS) Program for 2012. Moreover, to provide molecular characterization for associated resistance mechanisms and epidemiological typing.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research